Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

The purpose of this reissued Notice of Funding Opportunity (NOFO) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this NOFO supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated “Go/No-Go” criteria by the end of Year 2.

Topics: Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Computational or Data Science Methods Development, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Research Facilities Development, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Research Tool Development